Ragone R, Lavermicocca T, Maranzano F, De Renzo F, Labellarte C, Lasorella Ml, Milella L
{"title":"Effectiveness of Analgesia Nociception Index (ANI) As a Monitoring Tool to Evaluate Intraoperative Pain in Pediatric Patients Undergoing Sevofluorane Sedation and Locoregional Anesthesia","authors":"Ragone R, Lavermicocca T, Maranzano F, De Renzo F, Labellarte C, Lasorella Ml, Milella L","doi":"10.33425/2639-846x.1072","DOIUrl":"https://doi.org/10.33425/2639-846x.1072","url":null,"abstract":"Background: We present our results about pediatric patients undergoing sevofluorane sedation and locoregional anesthesia (LRA) referred for visceral, urological and orthopedic surgery, using Analgesia Nociception Index (ANI) as a monitoring tool for intraoperative pain. Objective: The aim of this study was to evaluate the effectiveness of ANI to provide assessment of locoregional anesthesia success (opiod-free anesthesia) following skin incision in pediatric patients sedated with sevofluorane. Materials and Methods: We enrolled 60 patients aged 2-17 years from September 2022 to November 2022. All patients were eligible for locoregional anesthesia, not suffering from cardiac arrhythmias, neurological disorders and not treated with opioids or drugs interfering with Autonomic Nervous System. Following preoperative assessment and consent, premedication with midazolam (0,5 mg/Kg per os) was used. Standard monitoring (SpO2 , HR, ECG, NIBP, body temperature sensor) and ANI was placed prior to induction of anesthesia. Once intravenous access had been established, anesthesia was induced with sevofluorane or propofol, was maintained with sevofluorane (MAC 1.3 in oxygen) and then ultrasound guided locoregional anesthesia was performed. ANI values were recorded prior to skin incision (T0) after 30 seconds (T1) and after 2 minutes (T2) from skin incision. A rise in HR≥10% from baseline occurring within the 2 minutes after skin incision was considered to be a LRA failure, which requires fentanest (1-2 γ/Kg). A rise in HR<10% from baseline occurring within the 2 minutes after skin incision was instead considered LRA success, not requesting opioid. Results: 43 patients presented LRA success and 17 patients presented LRA failure. In the LRA failure group, skin incision caused ANI values decrease (p<0,05) within 30 seconds from skin incision. We described that ANI<68 in the first 2 minutes following skin incision can identify LRA failure with a sensitivity of 100% and a specificity of 82.4% (AUC:0.984). Conclusion: ANI values rapidly decrease after skin incision in case of LRA failure and this tool, alone or in combination with HR changes, could guide anesthesiologists in using intraoperative opioid in children over 2 years of age sedated with sevofluorane.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139366328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mbombo W, Mbuyamba J, Mosolo A, Mbuyi F, Nkodila A, Isengingo C, Kambala P, Bazeboso Ja, Mbala T, Kazadi V, Mukaba P, Mbala R, Ilunga Jp, Mukuna P, Kashala R, Kabwe B, Kabango R, Nsiala J, Bula-Bula M, Barhayiga B, Makulo Jr, Ngiyulu Jr, T. L.
{"title":"Factors Associated with Morbidity and Mortality in Anesthesia During Intra-Abdominal Surgery in Sickle Cell Patients in a Low-Income Country: The Case of Centre Hospitalier Monkole","authors":"Mbombo W, Mbuyamba J, Mosolo A, Mbuyi F, Nkodila A, Isengingo C, Kambala P, Bazeboso Ja, Mbala T, Kazadi V, Mukaba P, Mbala R, Ilunga Jp, Mukuna P, Kashala R, Kabwe B, Kabango R, Nsiala J, Bula-Bula M, Barhayiga B, Makulo Jr, Ngiyulu Jr, T. L.","doi":"10.33425/2639-846x.1073","DOIUrl":"https://doi.org/10.33425/2639-846x.1073","url":null,"abstract":"Objective: This study investigated the factors associated with morbidity and mortality in sickle cell patients anesthetized for intra-abdominal surgery in Monkole. Methods: Prospective study conducted in sickle cell patients anesthetized for intra-abdominal surgery (excluding cesarean section) from 01/01/2011 to 12/31/2020 and recruited exhaustively and consecutively. The variables studied were pre, per and postoperative until discharge from hospital. Data were analyzed with SPSS 24.0 for p < 0.05. Results: Of 258 anesthetized sickle cell patients, 74 were for intra-abdominal surgery, including 59.5% of women with an average age of 16.4 years. The majority (95%) were transfused several time, 18% were under hydrea and none under exchange transfusion. Jaundice was present in 49%, heart murmur in 22%, 96% were ASA III. Anesthetic duration was ≥ 2 hours in 59.5%. Simple transfusion was done in 63.5% of cases. Intraoperative incidents accounted for 4% (bronchospasm, hypercapnia and allergy). Postoperative complications (anemia, parietal infection, convulsions, pancreatitis, pneumonia) accounted for 20% and 3 deaths were recorded (sepsis: 2 and pulmonary embolism: 1). Splenic surgery [ORa: 4.35 (1.51-7.20 95% CI) p=0.018]; the presence of jaundice [ORa: 3.18 (1.04-7.80 95% CI) p=0.024] and duration of anesthesia ≥ 2 hours [ORa: 9.09 (1.27-12.87 95% CI p=0.033] were the determinants of intraoperative transfusion. Heart murmur [ORa: 10.50 (2.77-13.76 95% CI) p=0.001] and hemoglobin <6g/dl [ORa: 3.08 (2.82-17.59 95% CI) p =0.008] were associated with postoperative complications. Conclusion: Morbi-mortality seems linked to the severity of the surgery and the pathology and not to the anesthesia act.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139367526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Beth Baughman DuPree, Jason Wesley, Estelle Farrell, Paul Lewis
{"title":"A Pilot Study of the Signal ReliefTM Patch for the Treatment of Musculoskeletal Pain","authors":"Beth Baughman DuPree, Jason Wesley, Estelle Farrell, Paul Lewis","doi":"10.33425/2639-846x.1075","DOIUrl":"https://doi.org/10.33425/2639-846x.1075","url":null,"abstract":"The aim of this IRB approved study was to evaluate the efficacy of the non-invasive, drug-free, re-usable patch, Signal ReliefTM, for the management of general musculoskeletal pain. Pain severity was assessed at baseline and upon completion of 7-day treatment schedule using Visual Analog Pain Scale (VAS), Brief Pain Inventory form (BPI) and Pain Interference Score (PIS). Reduction in pain medication use was evaluated via pain medication diary. An optional, exploratory endpoint of Substance P blood serum levels at baseline and end of treatment was also assessed. We enrolled 42 subjects with 2 board-certified physicians, one primary care and one a pain specialist. Thirty-two subjects completed the trial. Seventy five percent (24/32) subjects had a ≥ 30% reduction in pain on VAS. The average reduction in pain per VAS, BPI and PSI for the cohort was 59.7% (-65.6, -53.7); 44% (-53.1, -34.9); and 47.4% (-53.7, -41.1) respectively. Sixty eight percent (22/32) subjects were taking pain medication upon study entry. Reduction in pain medication use demonstrated was a 96.5% decrease for non-opioids and 91.4% decrease for opioids. Substance P levels were collected for 24 subjects. While 50% of subjects (12/24) showed a reduction in Substance P levels there was an overall increase of 11.7% across the entire cohort. Safety assessments included physical examination, monitoring of vital signs, and adverse event reporting per study visit schedule. No adverse events were reported. Our findings suggest that the Signal ReliefTM may be an effective non-invasive, drug-free option for the management of general musculoskeletal pain.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139367348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Etoundi, Marie Elvire Nokam Taguemne, Gouag G, Michèle Kamga, Armandine Beyene Akoa, Ze Minkande Jacqueline
{"title":"Failure of Locoregional Anaesthesia in Dental Practice: Frequency, Causes and Replacement Strategies","authors":"P. Etoundi, Marie Elvire Nokam Taguemne, Gouag G, Michèle Kamga, Armandine Beyene Akoa, Ze Minkande Jacqueline","doi":"10.33425/2639-846x.1071","DOIUrl":"https://doi.org/10.33425/2639-846x.1071","url":null,"abstract":"Background: Locoregional anaesthesia (LRA) is frequently practiced in odontostomatology. Our aim was to determine the frequency and causes of LRA failures and to evaluate replacement strategies in two peripheral hospitals in Cameroon. Methodology: A prospective and descriptive study was carried out in the department of odonto-stomatology of the Ebolowa Regional Hospital and Efoulan District hospital of Cameroon from the 1st of January to the 31st of August 31st 2022. Were included, patients presenting an oral pathology requiring LRA. The variables studied were: failure rate of LRA, the reasons of failure, the strategies used after failure and their efficiency. Data analysis was performed using Epi Info 3.5.4 software. The chi-square test was used, the p-value being considered significant if < 0.05. Results: The study sample consisted of 301 patients. The mean age was 29.9 ± 17.7 years and the sex ratio 1.3. The main pathologies were pulpopathies (47.8%). The most practiced nerve block was the truncal spina Spix anaesthesia (51.8%) with lidocaine and epinephrine. The failure rate of anaesthesia procedure was 73.4% due to the technique used. The strategies employed in case of failure were efficient in 81.4% of cases. Intra-pulpal and intra-septal anaesthesia were particularly mastered. Conclusion: Failures of LRA in odontostomatology in peripheral hospitals are very recurrent. It’s due to the lack of qualified experienced personnel. Strategies employed in the event of failure are efficient particularly intra-pulpal and intra-septal anaesthesia.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139367703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bula-Bula M, N’sinabau R, Kabuni P, Nkoy B, Ndjoko S, Lenge N, Ngalala M, Ilunga Jp
{"title":"Early Diagnosis of Esophageal Intubation: Primary Auscultation of the Armpits Versus Epigastrum","authors":"Bula-Bula M, N’sinabau R, Kabuni P, Nkoy B, Ndjoko S, Lenge N, Ngalala M, Ilunga Jp","doi":"10.33425/2639-846x.1074","DOIUrl":"https://doi.org/10.33425/2639-846x.1074","url":null,"abstract":"Esophageal intubation is a common accident and failure to detect it can result in fatality. The objective of this study is to suggest the primary the auscultation of the epigastric area as mean of rapid diagnosis of esophageal intubation. A cross sectional study was carried out at the N’djili hospital in Kinshasa from June to September 2020. The sampling was randomly made and two groups of the population were selected. In the study group, the endotracheal intubation was indirectly confirmed by the absence of borborygmi on auscultation of the of epigastric area whereas in the control group, it was confirmed by the presence of vesicular murmur in armpits. After intubation, the investigator counted the time from the moment the chest piece of the stethoscope was placed in the armpit to confirm tracheal intubation or on the epigastric area to rule out esophageal intubation. The chest compression was also performed to check fogging of endotracheal tube. The time counted was the time between the placement of the chest piece of the stethoscope and the diagnosis of esophageal intubation. Seven cases of esophageal intubation were recorded out of sixty-two patients intubated. The average time for diagnosing esophageal intubation was 15 ± 5.6 seconds in the study group and 24 ± 3.2 seconds in the control group (Z= 8.035; p < 0.0001). Based on the time recorded, the primary auscultation of the epigastric area can quickly detect esophageal intubation as opposed to the auscultation of the armpit. “The sign the cross” could be used as chronogram to confirm tracheal placement of the tube.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139367203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Etoundi, Roddy Stephan Bengono Bengono, Albert Ludovic Amengle, C. Iroume, B. Jemea, Ze Minkande Jacqueline
{"title":"Epidemiological and Prognostic Aspects of Secondary Brain Insults of Systemic Origin in Patients Operated for Intracranial Tumor in Low-Resource Settings","authors":"P. Etoundi, Roddy Stephan Bengono Bengono, Albert Ludovic Amengle, C. Iroume, B. Jemea, Ze Minkande Jacqueline","doi":"10.33425/2639-846x.1069","DOIUrl":"https://doi.org/10.33425/2639-846x.1069","url":null,"abstract":"Background: Secondary Brain Insults of Systemic Origin (SBISO) are factors that can aggravate a primary brain injury regardless of its origin (traumatic, vascular, infectious, tumoral, or surgical). The aim was to describe the type and frequency of SBISO occurring after intracranial surgery indicated for intracranial tumors, and to establish the prognosis of patients presenting with these SBISO. Methods: This was a prospective and descriptive study carried out at the ICU of the Yaoundé Central Hospital between January 1st, 2012 to December 31st, 2019. We enrolled patients operated for intracranial tumors and admitted in the ICU. The variables studied were data from the preoperative, intraoperative and postoperative periods. Data analysis was performed using Epi Info 3.5.4 software. The chi-square test was used, the p-value being considered significant if < 0.05. Results: 93 patients were included during the period of study. The mean age was 45 ± 17.1 years and a sex- ratio of 1.27. We found 604 SBISO in 70 patients (75.3%). The most common SBISO were hypoxia (44.7%) and hyperglycemia (30%). The risk factors for the occurrence of SBISO were age ≥ 60 years (p=0.02), history of hypertension (p=0.005), patients classified ASA II (p=0.007) and intraoperative complications (p ? 0.001). The occurrence of SBISO was associated with a high mortality risk. Conclusion: SBISO are common in patients operated for intracranial tumors. Mortality was increased by the presence of SBISO.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"102 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133171370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dichtwald Sara, Khashan Ahmed, M. Avraham, Gorfil Dan M, Ifrach Nisim, Drori Idan
{"title":"Life-Threatening Amniotic Fluid Emboli Requiring Massive Blood Transfusion and Veno-Arterial Extracorporeal Membrane Oxygenation Therapy: Case Report and Review of the Literature","authors":"Dichtwald Sara, Khashan Ahmed, M. Avraham, Gorfil Dan M, Ifrach Nisim, Drori Idan","doi":"10.33425/2639-846x.1067","DOIUrl":"https://doi.org/10.33425/2639-846x.1067","url":null,"abstract":"Background: Amniotic fluid embolism (AFE) is a rare and disastrous condition that occurs during labor or soon after delivery. Its course is abrupt and rapidly progressive and may result in cardiorespiratory collapse, profound hemorrhage and multi organ failure. Mortality and morbidity are high, with many survivors suffering major neurologic sequelae. Disseminated intravascular coagulation (DIC), severe coagulopathy and hemorrhage may pose a risk for extracorporeal membrane oxygenation (ECMO) therapy due to the need of full anticoagulation treatment. Case Report: A 41 year old healthy parturient who developed fulminant AFE during cesarean delivery, accompanied by cardiac arrest, severe acute respiratory distress syndrome and DIC with profound obstetric hemorrhage. She was placed on veno-arterial ECMO as a rescue therapy and required more than 850 blood products. She had concomitant septic shock with E-coli bacteremia due to chroioamnionitis. Despite prolonged and complicated ICU course, including recurrent hemorrhage, multiple surgeries and sepsis, she survived to hospital discharge without neurologic sequelae. Conclusion: ECMO therapy may be considered as a rescue therapy in AFE cases, refractory to standard cardiorespiratory support, despite the increased risk for hemorrhage under full anticoagulation therapy. Interdisciplinary coordination is mandatory for a good outcome.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116682133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeffrey Gudinx, D. Dietze, Galen Dhaliwal, Peter L Hurwitz
{"title":"Haptic Vibrotactile Trigger Technology: Disrupting the Neuromatrix to Reduce Pain Severity and Interference: Results from the HARMONI Study","authors":"Jeffrey Gudinx, D. Dietze, Galen Dhaliwal, Peter L Hurwitz","doi":"10.33425/2639-846x.1070","DOIUrl":"https://doi.org/10.33425/2639-846x.1070","url":null,"abstract":"The prevalence of pain and pain-related diseases are so vast that they are the leading causes of disability and disease burden across the globe. Over 100 million people are estimated to live with chronic or recurrent pain in the United States and it is the most common reason patients consult primary care clinicians. Conventional pharmacological treatments for pain have been associated with dangerous adverse effects. Identifying effective, alternative treatment strategies, including those that are non-invasive and non-pharmacologic and that have reduced and limited side effect profiles, will provide options that may be preferable in how clinicians traditionally treat pain. Understanding the pain neuromatrix may assist in identifying these alternative approaches that reduce pain severity and interference, and that improve patient outcomes. The neuromatrix of pain is a network of neuronal pathways and circuits responding to sensory (nociceptive) stimulation. Researchers have shown that these pathways and areas of the brain that are associated with the neuromatrix can change in response to external stimuli. Haptic vibrotactile trigger technology (VTT) is designed to target the nociceptive pathways and theorized to disrupt the neuromatrix of pain. The technology has been incorporated into non-invasive, non-pharmacological topical patches and other routes of delivery. The purpose of this IRB-approved, minimal risk study was to evaluate patients’ experiences and/or perceptions and patient response for those who received a haptic vibrotactile trigger technology (VTT) embedded non-pharmacologic, non-invasive, over-the-counter pain patch (FREEDOM Super Patch with VTT; Srysty Holding Co, Toronto, Canada). Methods: Baseline, 7- and 14-day data were recorded in one hundred forty-eight (148) adult subjects (96 females and 52 males) with a mean age of 53 years who presented with mild, moderate and even severe musculoskeletal, arthritic and neurological pain. The study evaluated changes in overall severity and interference scores via a validated scale (Brief Pain Inventory (BPI)), changes in the use of prescription and OTC medications, patient satisfaction, and any side effects reported while using the patch. Future analyses will compare the outcomes reported here with non-active control and crossover treatment groups. Results: The results showed statistically significant decreases in mean BPI severity and interference scores after using the VTT embedded pain patch. After 14 days, the vast majority of patients reported “less” or “a lot less” usage of oral medications and were very/extremely satisfied with the patch. Results also showed statistically significant and positive outcomes in all measured Quality of Life (QoL) components with improvements in general activity, mood, relations with other people, sleep, normal work, walking ability, and enjoyment of life. Conclusions: Study results indicate that this non-pharmacologic, non-invasive, haptic vibrotactile tr","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134540383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Baldeep Dhaliwal, John W Haddad, Mark Debrincat, Peter L Hurwitz
{"title":"Changes in Electroencephalogram (EEG) After Foot Stimulation with Embedded Haptic Vibrotactile Trigger Technology: Neuromatrix and Pain Modulation Considerations","authors":"Baldeep Dhaliwal, John W Haddad, Mark Debrincat, Peter L Hurwitz","doi":"10.33425/2639-846x.1068","DOIUrl":"https://doi.org/10.33425/2639-846x.1068","url":null,"abstract":"Background: Globally, pain and pain-related diseases are the leading causes of disability and disease burden. In the United States, pain is the most common reason patients consult primary care providers. An estimated 100 million people live with chronic or recurrent pain. Existing pharmacological treatments for pain include anti-inflammatory agents, opioids, and other oral and topical analgesics. Many of these have been associated with troublesome and potentially harmful adverse effects. Understanding the complex pain neuromatrix may help in identifying alternative, non-invasive strategies and treatment approaches to address pain severity, interference, and improve patient outcomes. The neuromatrix of pain is a network of neuronal pathways and circuits responding to sensory (nociceptive) stimulation. Research has suggested that the output patterns of the body-self neuromatrix are responsible for causing or triggering perceptual, homeostatic, and behavioral programs following traumatic injury, other pathology, or chronic stress. As such, pain can be considered a product of the output of a widely distributed neural network within the brain instead of a sequential result of sensory inputs triggered by injury, inflammation, or other pathology. For over a century, the Brodmann Areas remain the most widely known and frequently cited cytoarchitectural organization of the human cortex. Certain Brodmann areas of the brain have been associated with the current understanding of the neuromatrix of pain. The areas expands well beyond the thalamus and anterior cingulate, and primary (S1) and secondary (S2) somatosensory cortices to include the midbrain region of the periaqueductal gray (PAG) and the lenticular complex as well as the insula, orbitofrontal (Brodmann's area [BA] 11, 47), prefrontal (BA 9, 10, 44-46), motor (BA 6, Supplementary motor area, and M1), inferior parietal (BA 39, 40), and anterior cingulate (BA 24, 25) cortices (ACCs). Treatments that are non-invasive and non-pharmacological and target both central and peripheral nociceptive mechanisms that are identified as having an impact on the Brodmann areas associated with the neuromatrix of pain may potentially be considered a beneficial pain management option for patients. Haptic vibrotactile trigger technology targets the nociceptive pathways and is theorized to disrupt the neuromatrix of pain. The technology has been incorporated into non-pharmacological patches and other non-invasive routes of delivery such as apparel (socks), braces, wristbands, and compression sleeves. The purpose of this minimal risk study was to compare electroencephalogram (EEG) patterns in areas of the brain that have been associated with the neuromatrix for pain in subjects wearing socks that were embedded with haptic vibrotactile trigger technology with those patients that wore socks that were not embedded with the technology. Methods: This IRB-approved study compared electroencephalogram (EEG) patterns in subjects we","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115400709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anesthetic Management for Patient with Poems Syndrome","authors":"K. A., K. T., Okabe T, Furuichi Y, Sakamoto A","doi":"10.33425/2639-846x.1066","DOIUrl":"https://doi.org/10.33425/2639-846x.1066","url":null,"abstract":"We provided anesthesia for a 65-year-old female undergoing right lumpectomy. Preoperative examination revealed significant ascites and heart failure. Additional examination confirmed increased level of M protein, plasma vascular and endothelial growth factor (VEGF), as well as polyneuropathy. The patient was diagnosed with POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy and Skin abnormalities) syndrome, in which prolonged duration of action of neuromuscular blocking agents has been reported. Anesthesia was maintained with sevoflurane and remifentanil. We monitored the effects of rocuronium bromide using TOF-WatchTM. In this case, we did not find any prolonged effect of neuromuscular blocking agents and we successfully performed perioperative anesthetic management.","PeriodicalId":229124,"journal":{"name":"Anesthesia & Pain Research","volume":"93 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125541409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}